{"about":{"non_affiliation":"Code with Papers and Syntology are not affiliated with, endorsed by, or sponsored by Papers with Code, Meta, or the pwc-archive mirror.","site":"https://codewithpapers.app","licence":"CC BY-SA 4.0","licence_url":"https://creativecommons.org/licenses/by-sa/4.0/legalcode","attribution":"https://codewithpapers.app/attribution","modified":"archive material modified by Syntology; see the attribution page","syntology":{"site":"https://syntology.ai","developers":"https://syntology.ai/developers","mcp":{"server":"https://syntology.ai/mcp","transport":"streamable-http","server_card":"https://syntology.ai/.well-known/mcp/server-card.json","auth":{"type":"trial token, no account","trial_token":"https://syntology.ai/api/oauth/trial/token","method":"POST","docs":"https://syntology.ai/developers"}},"have":"https://syntology.ai/api/graph/have?x=<method, arXiv id or title> (free, answers coverage only)","paper_base":"https://syntology.ai/paper/","atlas_base":"https://app.syntology.ai/?focus="},"machine_readable":[{"url":"https://codewithpapers.app/llms.txt","what":"the machine catalog: every machine-readable file, counted"},{"url":"https://codewithpapers.app/index/manifest.json","what":"paper-to-code index by arXiv id, with Syntology's counts"},{"url":"https://codewithpapers.app/search/manifest.json","what":"site search index (titles, authors) and its files"},{"url":"https://codewithpapers.app/download","what":"bulk files: Syntology's layer, described there"},{"url":"https://codewithpapers.app/build_manifest.json","what":"the build record: inputs, counts, exclusions, probes"}]},"url":"/paper/novomol-recurrent-neural-network-for-orally","title":"NovoMol: Recurrent Neural Network for Orally Bioavailable Drug Design and Validation on PDGFRα Receptor","arxiv_id":"2312.01527","date":"2023-12-03","proceeding":null,"authors":["Ishir Rao"],"abstract":"Longer timelines and lower success rates of drug candidates limit the productivity of clinical trials in the pharmaceutical industry. Promising de novo drug design techniques help solve this by exploring a broader chemical space, efficiently generating new molecules, and providing improved therapies. However, optimizing for molecular characteristics found in approved oral drugs remains a challenge, limiting de novo usage. In this work, we propose NovoMol, a novel de novo method using recurrent neural networks to mass-generate drug molecules with high oral bioavailability, increasing clinical trial time efficiency. Molecules were optimized for desirable traits and ranked using the quantitative estimate of drug-likeness (QED). Generated molecules meeting QED's oral bioavailability threshold were used to retrain the neural network, and, after five training cycles, 76% of generated molecules passed this strict threshold and 96% passed the traditionally used Lipinski's Rule of Five. The trained model was then used to generate specific drug candidates for the cancer-related PDGFR{\\alpha} receptor and 44% of generated candidates had better binding affinity than the current state-of-the-art drug, Imatinib (with a receptor binding affinity of -9.4 kcal/mol), and the best-generated candidate at -12.9 kcal/mol. NovoMol provides a time/cost-efficient AI-based de novo method offering promising drug candidates for clinical trials.","url_abs":"https://arxiv.org/abs/2312.01527v1","url_pdf":"https://arxiv.org/pdf/2312.01527v1.pdf","source":{"archive":"pwc-archive (Hugging Face), CC BY-SA 4.0","snapshot":"2025-07-28","licence_url":"https://creativecommons.org/licenses/by-sa/4.0/legalcode","row_kind":"abstracts"},"code_links":[{"paper_slug":"novomol-recurrent-neural-network-for-orally","repo_url":"https://github.com/ishirraov/novomol","is_official":1,"mentioned_in_paper":1,"mentioned_in_github":0,"framework":"none","reach":null}],"tasks":[{"task_slug":"drug-design","task_name":"Drug Design"}],"methods":[],"datasets_introduced":[],"methods_introduced":[],"results":[],"syntology":{"syntology_url":null,"atlas_url":null,"mcp":null,"developers":"https://syntology.ai/developers","held":null,"reason":"arxiv_id_not_in_atlas","checked_against":{"atlas_ids":549449,"atlas_ids_sha256":"afd72399dafd9906e9062927f70655952385a3d75488558e1f0484e950ab09b7","read_at":"2026-10-05T01:46:21Z"},"by_repo":[{"repo":"ishirraov/novomol","kind":"official","samples":0,"ran":0,"instrument":0,"unverified":0}],"by_repo_is":"one row per repository in the archive's code links, Syntology's graph links or the samples; samples 0 means no sample is linked to this paper, a statement about Syntology's coverage, not about the repository: with harvested_for_other_papers present, Syntology harvested the repository for that many other papers, and without it, Syntology harvested nothing from it; placed_by_identical_code counts samples whose link records no repository, placed here because identical code was harvested from this repository for another paper; ran counts executions on a synthesized input and instrument counts failures of Syntology's instrument, not of the code"},"code_links_note":null,"arxiv_metadata":null,"syntology_extracted_results":null,"record_sha256":"6ff9d2a5e49f1cff8b3717e7fdeb388823361cfeb0b25ea45e625f80aa40570d","record_changed_at":"2026-09-28","record_changed_at_basis":"first_hashed"}